This inventor holds 10 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Kythera Biopharmaceuticals, Inc., Allergan Sales, Inc.. Active years: 2012-2021.
Location History:
- Thousand Oaks, CA (US) (2012 - 2021)
- Carmel, CA (US) (2021)
Company Filing History:
Years Active: 2012-2021
Title: **The Innovative Journey of Jeffrey Douglas Webster**
Introduction
Jeffrey Douglas Webster, an accomplished inventor based in Thousand Oaks, California, has made significant contributions to the field of pharmaceuticals. With a portfolio of 10 patents, his work primarily focuses on the formulation of deoxycholic acid and its derivatives, showcasing his dedication to improving medical treatments through innovation.
Latest Patents
Webster's most recent patents include two noteworthy applications related to aqueous pharmaceutical formulations. The first patent is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate, maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Additionally, it discloses methods for inhibiting precipitation in solutions while maintaining pH levels from about 8.0 to about 8.5. The second patent also focuses on formulations of deoxycholic acid, revealing an aqueous composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid. This composition is stabilized against precipitation by maintaining a pH from about 8.1 to about 8.5.
Career Highlights
Throughout his career, Jeffrey Webster has worked with reputable companies, including Kythera Biopharmaceuticals, Inc. and Allergan Sales, Inc. His roles in these organizations have enabled him to apply his expertise in pharmaceutical formulations, contributing to the advancement of medical science.
Collaborations
Webster has collaborated with several talented individuals in the industry. Notable coworkers include Robert Emil Hodge and Robert M. Moriarty, with whom he has shared insights and knowledge, further enriching his understanding and enhancing his innovations in the field.
Conclusion
Jeffrey Douglas Webster continues to be a pioneering force in pharmaceutical innovation, particularly through his work on deoxycholic acid formulations. His patents not only reflect his inventive spirit but also contribute to the scientific community's broader efforts in developing effective medical solutions. As he advances in his career, he remains a vital asset to the realm of pharmaceutical research and innovation.